Loss of "insight" into behavioral changes in ALS: Differences across cognitive profiles.


Journal

Brain and behavior
ISSN: 2162-3279
Titre abrégé: Brain Behav
Pays: United States
ID NLM: 101570837

Informations de publication

Date de publication:
01 2022
Historique:
revised: 04 10 2021
received: 01 04 2021
accepted: 06 11 2021
pubmed: 3 12 2021
medline: 15 3 2022
entrez: 2 12 2021
Statut: ppublish

Résumé

Behavioral impairment occurs in amyotrophic lateral sclerosis (ALS) and ALS-fronto-temporal dementia (ALS-FTD). It has been proposed that ALS patients without FTD retain an awareness of their behavioral impairment while ALS-FTD patients lose this awareness (referred to as retention vs. loss of "insight"). Loss of insight has not yet been studied across the entire ALS-FTD spectrum; our study addresses this gap by including patients with all the ALS cognitive-behavioral profiles. Eighty-three ALS patients (and their informants) took part in this bicentric study involving two German recruitment sites. Patients and informants completed the Frontal Systems Behavior Scale covering the domains of apathy, disinhibition, and executive dysfunctioning. Patients were classified into five groups according to the Strong and Rascovsky criteria: cognitively unimpaired (ALSni), cognitively impaired without dementia (ALSci), behaviorally impaired (ALSbi), a combination of behaviorally and cognitively impaired (ALScbi), and ALS-FTD. We applied Bayesian two-way ANOVA to test whether there were subgroup differences regarding insight into their behavioral decline. All patient subgroups experienced behavioral decline (Bayes factor > 3). Only ALS-FTD patients lost insight into disinhibition and executive dysfunctioning. ALSbi patients exhibited worse insight than ALSni and ALSci patients (Bayes factor > 10). Evidence regarding the ALScbi patients was inconclusive. Higher IQ was associated with worse insight (Bayes factor > 3). Our findings provide solid support for the notion that ALS patients without dementia experience behavioral decline regardless of their cognitive-behavioral profile and retain different levels of insight into this decline. The inverse association of premorbid verbal intelligence with insight was unexpected, leaving room for further investigation.

Identifiants

pubmed: 34855301
doi: 10.1002/brb3.2439
pmc: PMC8785632
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2439

Informations de copyright

© 2021 The Authors. Brain and Behavior published by Wiley Periodicals LLC.

Références

J Neuropsychiatry Clin Neurosci. 2006 Spring;18(2):186-90
pubmed: 16720795
Eur J Neurol. 2010 Jan;17(1):103-10
pubmed: 19874396
Brain Cogn. 2007 Feb;63(1):13-23
pubmed: 16914245
Cortex. 2021 Jun;139:240-248
pubmed: 33892294
J Neurol Neurosurg Psychiatry. 2021 May;92(5):460-465
pubmed: 33563807
J Neurol. 2017 Jul;264(7):1397-1401
pubmed: 28600595
Psychon Bull Rev. 2018 Feb;25(1):35-57
pubmed: 28779455
Front Neurosci. 2019 Sep 10;13:951
pubmed: 31551700
Clin Neurophysiol. 2016 Dec;127(12):3537-3545
pubmed: 27825054
Amyotroph Lateral Scler. 2010 May 3;11(3):303-11
pubmed: 20433413
J Neurol Neurosurg Psychiatry. 2016 Jun;87(6):611-9
pubmed: 26283685
Neurology. 2005 Aug 23;65(4):586-90
pubmed: 16116120
Neurology. 2012 Sep 25;79(13):1377-83
pubmed: 22972650
Neurobiol Aging. 2021 Feb;98:205-213
pubmed: 33316576
Brain. 2011 Sep;134(Pt 9):2456-77
pubmed: 21810890
Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3-4):153-174
pubmed: 28054827
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9
pubmed: 11464847
Neurology. 1998 Dec;51(6):1546-54
pubmed: 9855500
Arch Clin Neuropsychol. 2005 Jun;20(4):505-15
pubmed: 15896563
BMC Neurosci. 2014 Jun 30;15:83
pubmed: 24981872
J Neurol Sci. 2011 Oct 15;309(1-2):136-40
pubmed: 21782199
Front Mol Neurosci. 2016 Oct 13;9:92
pubmed: 27790088
Amyotroph Lateral Scler Frontotemporal Degener. 2021 May;22(3-4):237-247
pubmed: 33263428
Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1-2):68-73
pubmed: 27894191
Behav Neurol. 2008;19(3):107-16
pubmed: 18641430
Perspect Psychol Sci. 2012 Nov;7(6):537-42
pubmed: 26168110
J Neurol Neurosurg Psychiatry. 2018 Sep;89(9):995-1002
pubmed: 29439163
J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):675-680
pubmed: 28596248
J Neurol Sci. 2001 Oct 15;191(1-2):103-9
pubmed: 11676999
Amyotroph Lateral Scler Frontotemporal Degener. 2015 Jun;16(3-4):160-71
pubmed: 25967541
Amyotroph Lateral Scler. 2010;11(1-2):52-6
pubmed: 19714539
Amyotroph Lateral Scler. 2007 Feb;8(1):56-61
pubmed: 17364437
J Pers. 2004 Oct;72(5):1029-68
pubmed: 15335336
Psychon Bull Rev. 2018 Feb;25(1):58-76
pubmed: 28685272
J Clin Exp Neuropsychol. 2021 Feb;43(1):78-90
pubmed: 33550917
Behav Genet. 1989 Mar;19(2):223-7
pubmed: 2719625
Amyotroph Lateral Scler Frontotemporal Degener. 2014 Jun;15(3-4):298-304
pubmed: 24863641
Neurodegener Dis. 2016;16(3-4):184-91
pubmed: 26613522
Amyotroph Lateral Scler. 2012 Oct;13(6):493-501
pubmed: 22424127
Dementia (London). 2016 Nov;15(6):1622-1642
pubmed: 25645139
Brain Sci. 2020 Dec 23;11(1):
pubmed: 33374658
Neurology. 2014 Jan 14;82(2):149-55
pubmed: 24336140
J Neurol Neurosurg Psychiatry. 2016 Jun;87(6):663-9
pubmed: 26203157
Brain Behav. 2022 Jan;12(1):e2439
pubmed: 34855301
Psychon Bull Rev. 2007 Oct;14(5):779-804
pubmed: 18087943
J Neurol Neurosurg Psychiatry. 2015 Feb;86(2):168-73
pubmed: 24769471

Auteurs

Anna G M Temp (AGM)

German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, Rostock, Germany.

Elisabeth Kasper (E)

Department of Neurology, Rostock University Medical Center, Rostock, Germany.

Stefan Vielhaber (S)

Department of Neurology, Otto-von-Guericke University, Magdeburg, Germany.
German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.

Judith Machts (J)

Department of Neurology, Otto-von-Guericke University, Magdeburg, Germany.
German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.

Andreas Hermann (A)

German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, Rostock, Germany.
Translational Neurodegeneration Section "Albrecht-Kossel", Department of Neurology, and Center for Transdisciplinary Neurosciences Rostock (CTNR), University Medical Center Rostock, University of Rostock, Rostock, Germany.

Stefan Teipel (S)

German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, Rostock, Germany.
Department of Psychosomatic Medicine, Rostock University Medical Center, Rostock, Germany.

Johannes Prudlo (J)

German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, Rostock, Germany.
Department of Neurology, Rostock University Medical Center, Rostock, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH